Phase I study of a novel recombinant human soluble thrombomodulin, ART‐123
Open Access
- 28 September 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (10) , 1745-1751
- https://doi.org/10.1111/j.1538-7836.2004.00927.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip ArthroplastyArchives of internal medicine (1960), 2003
- Prevention of Venous ThromboembolismChest, 2001
- The Inhibitory Effect of Recombinant Human Soluble Thrombomodulin on Initiation and Extension of CoagulationThrombosis and Haemostasis, 1999
- Effects of Recombinant Human Soluble Thrombomodulin (rhs-TM) on Clot-induced Coagulation in Human PlasmaThrombosis and Haemostasis, 1998
- Plasma thrombomodulin in health and diseasesBlood, 1990
- Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogsBiochemistry, 1990
- Human thrombomodulin: complete cDNA sequence and chromosome localization of the geneBiochemistry, 1987
- Functional domains of rabbit thrombomodulin.Proceedings of the National Academy of Sciences, 1986
- Thrombomodulin is present in human plasma and urine.Journal of Clinical Investigation, 1985
- Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzymeBlood, 1982